[3H]nisoxetine: a new radioligand for norepinephrine uptake sites in brain.
about
Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preferenceVMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicityDominant negative isoform of rat norepinephrine transporter produced by alternative RNA splicingRelationship between cerebral sigma-1 receptor occupancy and attenuation of cocaine's motor stimulatory effects in mice by PD144418Norepinephrine activates dopamine D4 receptors in the rat lateral habenula.Differential effects of neonatal norepinephrine lesions on immediate early gene expression in developing and adult rat brain.Norepinephrine transporter regulation mediates the long-term behavioral effects of the antidepressant desipramine.Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.Tactics for preclinical validation of receptor-binding radiotracers.The antidepressants maprotiline and fluoxetine have potent selective antiproliferative effects against Burkitt lymphoma independently of the norepinephrine and serotonin transporters.Norepinephrine transporter: a candidate gene for initial ethanol sensitivity in inbred long-sleep and short-sleep mice.Functional significance of a highly conserved glutamate residue of the human noradrenaline transporter.A selective sigma-2 receptor ligand antagonizes cocaine-induced hyperlocomotion in mice.Dual phases of functional change in norepinephrine transporter in cultured bovine adrenal medullary cells by long-term treatment with clozapine.Extracellular norepinephrine reduces neuronal uptake of norepinephrine by oxidative stress in PC12 cells.
P2860
Q24603526-054DA262-FD29-4415-9694-074302EC91B4Q28512294-C6804519-0F74-4AE8-8E54-4EFE3BE02AC5Q28577553-624350FD-576F-41C0-B241-6AFF711D2AC9Q34186286-AD7C5E30-306B-4DE0-A2FD-DC3621954E45Q35117597-CD886E7F-E30E-4365-B8F9-B157EE94B607Q37132674-64713979-D488-4C0C-B6DB-415A2BC8704CQ37307278-92C80DBF-DE37-4408-8296-0F379D3DDFD6Q37307331-4ACAA4ED-7CDF-4F3E-81F4-6576195B30C8Q38984519-306163B3-591D-49CF-90C7-90AC6FADCA7BQ39742088-B2341316-8672-4708-8139-0C07CB83AE05Q40374995-9FDB982B-5726-49D1-8580-768746544D7DQ40725346-9EF0D107-CBE8-47D0-9FEA-8BCD36508A46Q43450779-A1D623E1-4DF4-4A5D-A132-467B0878611DQ43612884-B75A4651-C508-4055-9FDD-11126702961AQ44764123-BFDB1730-2C83-4A8E-9878-497A70C45490
P2860
[3H]nisoxetine: a new radioligand for norepinephrine uptake sites in brain.
description
1990 nî lūn-bûn
@nan
1990 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
[3H]nisoxetine: a new radioligand for norepinephrine uptake sites in brain.
@ast
[3H]nisoxetine: a new radioligand for norepinephrine uptake sites in brain.
@en
[3H]nisoxetine: a new radioligand for norepinephrine uptake sites in brain.
@nl
type
label
[3H]nisoxetine: a new radioligand for norepinephrine uptake sites in brain.
@ast
[3H]nisoxetine: a new radioligand for norepinephrine uptake sites in brain.
@en
[3H]nisoxetine: a new radioligand for norepinephrine uptake sites in brain.
@nl
prefLabel
[3H]nisoxetine: a new radioligand for norepinephrine uptake sites in brain.
@ast
[3H]nisoxetine: a new radioligand for norepinephrine uptake sites in brain.
@en
[3H]nisoxetine: a new radioligand for norepinephrine uptake sites in brain.
@nl
P2093
P1476
[3H]nisoxetine: a new radioligand for norepinephrine uptake sites in brain.
@en
P2093
Brunswick DJ
Tejani-Butt SM
P304
P356
10.1016/0014-2999(90)94155-Q
P407
P577
1990-11-01T00:00:00Z